1. Home
  2. ARQT vs FWRD Comparison

ARQT vs FWRD Comparison

Compare ARQT & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • FWRD
  • Stock Information
  • Founded
  • ARQT 2016
  • FWRD 1981
  • Country
  • ARQT United States
  • FWRD United States
  • Employees
  • ARQT N/A
  • FWRD N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • FWRD Oil Refining/Marketing
  • Sector
  • ARQT Health Care
  • FWRD Consumer Discretionary
  • Exchange
  • ARQT Nasdaq
  • FWRD Nasdaq
  • Market Cap
  • ARQT 1.1B
  • FWRD 970.3M
  • IPO Year
  • ARQT 2020
  • FWRD 1993
  • Fundamental
  • Price
  • ARQT $13.02
  • FWRD $27.94
  • Analyst Decision
  • ARQT Strong Buy
  • FWRD Hold
  • Analyst Count
  • ARQT 6
  • FWRD 4
  • Target Price
  • ARQT $17.00
  • FWRD $30.00
  • AVG Volume (30 Days)
  • ARQT 2.3M
  • FWRD 524.5K
  • Earning Date
  • ARQT 02-25-2025
  • FWRD 02-26-2025
  • Dividend Yield
  • ARQT N/A
  • FWRD N/A
  • EPS Growth
  • ARQT N/A
  • FWRD N/A
  • EPS
  • ARQT N/A
  • FWRD N/A
  • Revenue
  • ARQT $138,708,000.00
  • FWRD $2,179,844,000.00
  • Revenue This Year
  • ARQT $217.37
  • FWRD $86.25
  • Revenue Next Year
  • ARQT $55.64
  • FWRD $8.15
  • P/E Ratio
  • ARQT N/A
  • FWRD N/A
  • Revenue Growth
  • ARQT 182.84
  • FWRD 78.71
  • 52 Week Low
  • ARQT $6.99
  • FWRD $11.21
  • 52 Week High
  • ARQT $16.20
  • FWRD $40.92
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 50.16
  • FWRD 31.14
  • Support Level
  • ARQT $11.13
  • FWRD $30.28
  • Resistance Level
  • ARQT $13.62
  • FWRD $32.15
  • Average True Range (ATR)
  • ARQT 1.04
  • FWRD 1.42
  • MACD
  • ARQT 0.08
  • FWRD -0.29
  • Stochastic Oscillator
  • ARQT 67.26
  • FWRD 7.23

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight and Intermodal. The company generates maximum revenue from the Expedited Freight segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.

Share on Social Networks: